Neurogene Inc. sees significant stock purchases by Samsara BioCapital
Neurogene Inc. (NASDAQ:NGNE) recently witnessed substantial stock acquisitions by Samsara BioCapital, L.P. and its affiliates. On November 26, Samsara BioCapital acquired a total of 48,770 shares of Neurogene's common stock, with transaction prices …